Inventiva S.A. (IVA)
NASDAQ: IVA · IEX Real-Time Price · USD
2.610
-0.040 (-1.51%)
Jul 22, 2024, 10:11 AM EDT - Market open
Inventiva Employees
As of December 31, 2023, Inventiva had 123 total employees, including 120 full-time and 3 part-time employees. The number of employees increased by 10 or 8.85% compared to the previous year.
Employees
123
Change (1Y)
10
Growth (1Y)
8.85%
Revenue / Employee
$209,241
Profits / Employee
-$997,525
Market Cap
136.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Harvard Bioscience | 416 |
Amylyx Pharmaceuticals | 384 |
Cellectis | 221 |
Veru Inc. | 189 |
Electromed | 170 |
Invivyd | 95 |
Corvus Pharmaceuticals | 28 |
CervoMed | 8 |
IVA News
- 2 days ago - Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux - GlobeNewsWire
- 4 days ago - Inventiva announces a €20.1 million issuance of royalty certificates - GlobeNewsWire
- 16 days ago - Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position - GlobeNewsWire
- 4 weeks ago - Results of the votes of the Combined Shareholders' General Meeting of June 20, 2024 - GlobeNewsWire
- 7 weeks ago - Combined General Meeting of June 20, 2024 - Availability of the preparatory documents - GlobeNewsWire
- 2 months ago - Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024 - GlobeNewsWire
- 2 months ago - Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update - GlobeNewsWire
- 2 months ago - Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH - GlobeNewsWire